S. Crowe

640 total citations · 1 hit paper
16 papers, 461 citations indexed

About

S. Crowe is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Astronomy and Astrophysics. According to data from OpenAlex, S. Crowe has authored 16 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Molecular Biology and 3 papers in Astronomy and Astrophysics. Recurrent topics in S. Crowe's work include Diabetes Treatment and Management (6 papers), Astrophysics and Star Formation Studies (3 papers) and Stellar, planetary, and galactic studies (3 papers). S. Crowe is often cited by papers focused on Diabetes Treatment and Management (6 papers), Astrophysics and Star Formation Studies (3 papers) and Stellar, planetary, and galactic studies (3 papers). S. Crowe collaborates with scholars based in Germany, United States and Italy. S. Crowe's co-authors include I. Tikkanen, Uli C. Broedl, Hans J. Woerle, Robert Ćhilton, Odd Erik Johansen, Christopher P. Cannon, Stefano Del Prato, Maximilian von Eynatten, H.J. Woerle and S. Patel and has published in prestigious journals such as Journal of Clinical Oncology, The Astrophysical Journal and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

S. Crowe

14 papers receiving 450 citations

Hit Papers

Effects of empagliflozin on blood pressure and markers of... 2015 2026 2018 2022 2015 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes
    2015 372 citations Robert Ćhilton, I. Tikkanen et al. Diabetes Obesity and Metabolism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Crowe Germany 6 396 170 159 123 73 16 461
Steven Sambevski United States 5 336 0.8× 168 1.0× 134 0.8× 118 1.0× 90 1.2× 9 438
Annelie Blumrich Germany 8 230 0.6× 160 0.9× 80 0.5× 128 1.0× 90 1.2× 9 408
Jana Hricová Australia 5 280 0.7× 110 0.6× 147 0.9× 137 1.1× 46 0.6× 6 370
Cheng‐Hsuan Tsai Taiwan 11 287 0.7× 72 0.4× 233 1.5× 126 1.0× 61 0.8× 55 428
Laura Heenan United States 4 471 1.2× 165 1.0× 138 0.9× 94 0.8× 29 0.4× 7 532
Benjamin Bonnard France 12 225 0.6× 118 0.7× 101 0.6× 104 0.8× 66 0.9× 19 348
Christina Stahre Sweden 9 414 1.0× 174 1.0× 151 0.9× 87 0.7× 18 0.2× 12 524
Pieter M. Jansen Netherlands 10 298 0.8× 123 0.7× 154 1.0× 141 1.1× 38 0.5× 14 401
Maximilian Trum Germany 9 253 0.6× 169 1.0× 140 0.9× 203 1.7× 59 0.8× 17 400
Nobuko Maruyama Japan 12 566 1.4× 254 1.5× 321 2.0× 44 0.4× 67 0.9× 14 618

Countries citing papers authored by S. Crowe

Since Specialization
Citations

This map shows the geographic impact of S. Crowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Crowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Crowe more than expected).

Fields of papers citing papers by S. Crowe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Crowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Crowe. The network helps show where S. Crowe may publish in the future.

Co-authorship network of co-authors of S. Crowe

This figure shows the co-authorship network connecting the top 25 collaborators of S. Crowe. A scholar is included among the top collaborators of S. Crowe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Crowe. S. Crowe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Bally, John, S. Crowe, Adam Ginsburg, et al.. (2025). The JWST-NIRCam View of Sagittarius C. II. Evidence for Magnetically Dominated H ii Regions in the Central Molecular Zone. The Astrophysical Journal. 983(1). 20–20.
2.
Crowe, S., Jonathan C. Tan, Yichen Zhang, et al.. (2025). The JWST-NIRCam View of Sagittarius C. I. Massive Star Formation and Protostellar Outflows. The Astrophysical Journal. 983(1). 19–19. 1 indexed citations
3.
Tan, Jonathan C., Chi-Yan Law, Yichen Zhang, et al.. (2025). The SOFIA Massive (SOMA) Star Formation Survey. V. Clustered Protostars. The Astrophysical Journal. 986(1). 15–15.
4.
Prato, Stefano Del, S. Patel, S. Crowe, & Maximilian von Eynatten. (2016). Efficacy and safety of linagliptin according to patient baseline characteristics: A pooled analysis of three phase 3 trials. Nutrition Metabolism and Cardiovascular Diseases. 26(10). 886–892. 6 indexed citations
5.
Sattar, N, et al.. (2016). Potential relevance of changes in haematocrit to changes in lipid parameters with empagliflozin in patients with type 2 diabetes. Diabetologie und Stoffwechsel. 11(S 01). 8 indexed citations
6.
Ćhilton, Robert, I. Tikkanen, S. Crowe, et al.. (2015). 4B.03. Journal of Hypertension. 33(Supplement 1). e53–e53. 3 indexed citations
7.
Ćhilton, Robert, I. Tikkanen, Christopher P. Cannon, et al.. (2015). Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes. Diabetes Obesity and Metabolism. 17(12). 1180–1193. 372 indexed citations breakdown →
8.
Cherney, David, M. E. Cooper, I. Tikkanen, et al.. (2015). 4B.01. Journal of Hypertension. 33(Supplement 1). e53–e53. 7 indexed citations
9.
Ćhilton, Robert, I. Tikkanen, Christopher P. Cannon, et al.. (2015). 4B.02. Journal of Hypertension. 33(Supplement 1). e53–e53. 4 indexed citations
10.
Groop, Per‐Henrik, Stefano Del Prato, Marja‐Riitta Taskinen, et al.. (2014). Linagliptin treatment in subjects with type 2 diabetes with and without mild‐to‐moderate renal impairment. Diabetes Obesity and Metabolism. 16(6). 560–568. 41 indexed citations
11.
Rothermundt, Christian, Richard Cathomas, Arnoud J. Templeton, et al.. (2012). Metformin in Chemotherapy-Naïve Castration Resistant Prostate Cancer (CRPC): A Multicenter Phase II Trial (SAKK 08/09). Annals of Oncology. 23. ix302–ix302. 1 indexed citations
12.
Čihorić, Nikola, S. Crowe, Steffen Eychmüller, Daniel M. Aebersold, & Pirus Ghadjar. (2012). Clinically Significant Bleeding in Incurable Cancer Patients: Effectiveness of Hemostatic Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 84(3). S627–S628. 1 indexed citations
13.
14.
Baty, Florent, M. Frueh, S. Crowe, et al.. (2011). Whole blood transcriptomics analysis of 24h responses to bevacizumab/erlotinib in nonsquamous non-small cell lung cancer: A multicenter phase II trial SAKK19/05.. Journal of Clinical Oncology. 29(15_suppl). e21069–e21069. 1 indexed citations
15.
16.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steven Sambevski Breakdown of academic impact, for papers by Annelie Blumrich Breakdown of academic impact, for papers by Jana Hricová Breakdown of academic impact, for papers by Cheng‐Hsuan Tsai Breakdown of academic impact, for papers by Laura Heenan Breakdown of academic impact, for papers by Benjamin Bonnard Breakdown of academic impact, for papers by Christina Stahre Breakdown of academic impact, for papers by Pieter M. Jansen Breakdown of academic impact, for papers by Maximilian Trum Breakdown of academic impact, for papers by Nobuko Maruyama
Rankless by CCL
2026